共 48 条
- [1] Sergio H(2020)Epidemiology of idiopathic pulmonary fibrosis: a population-based study in primary care Intern. Emerg. Med. 15 437-445
- [2] Biondini D(2020)Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF): an overview of current and future therapeutic strategies Expert Rev Respir Med 14 405-414
- [3] Carrington R(2018)Use of animal models in IPF research Pulm Pharmacol Ther 51 73-78
- [4] Han MK(2014)Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study Lancet Respir Med 2 548-556
- [5] Molyneaux PL(2014)The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis Am J Respir Crit Care Med 190 906-913
- [6] O’Dwyer DN(2019)Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis Am J Respir Crit Care Med 199 1127-1138
- [7] Molyneaux PL(2017)Host-Microbial Interactions in Idiopathic Pulmonary Fibrosis Am J Respir Crit Care Med 195 1640-1650
- [8] Wu Y(2022)Gut microbiome and metabolites: The potential key roles in pulmonary fibrosis Front Microbiol 13 1200937-963
- [9] Shi H(2023)The associations between gut microbiota and chronic respiratory diseases: a Mendelian randomization study Front Microbiol 14 5-57
- [10] Quan Y(2022)The gut-lung axis: Gut microbiota changes associated with pulmonary fibrosis in mouse models induced by bleomycin Front Pharmacol 13 1401-1500